Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak cannabis stocks Tilray Brands (TLRY), Canopy Growth (CGC), Cronos Group (CRON), and Aurora Cannabis (ACB). Keep reading…